Dynamic Technology Lab’s C4 Therapeutics CCCC Stock Holding History

Dynamic Technology Lab’s Portfolio CCCC Stock Details CCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153K	Buy	+32,828	New	+$112K	0.03%	577
2025 Q3	–	Sell	-21,476	Closed	-$31K	–	855
2025 Q2	$31K	Buy	+21,476	New	+$31.2K	﹤0.01%	879
2023 Q3	–	Sell	-12,708	Closed	-$35K	–	984
2023 Q2	$35K	Buy	12,708 +529	+4%	+$1.7K	﹤0.01%	933
2023 Q1	$38K	Buy	+12,179	New	+$71.7K	﹤0.01%	1008
2022 Q3	–	Sell	-32,933	Closed	-$248K	–	1151
2022 Q2	$248K	Buy	32,933 +11,043	+50%	+$97.2K	0.03%	837
2022 Q1	$531K	Buy	21,890 +9,930	+83%	+$241K	0.06%	553
2021 Q4	$385K	Buy	+11,960	New	+$473K	0.04%	709

Other funds holding CCCC

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dynamic Technology Lab's CCCC Position: Q2 2026 in Review

Dynamic Technology Lab opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 32,828 shares worth $153K. The stake represents 0.03% of the portfolio and ranks #577 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in CCCC as recently as Q2 2025.

Dynamic Technology Lab first reported a position in CCCC in Q4 2021 and has held it in 7 quarters since. The position peaked at $531K in Q1 2022. 148 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

Dynamic Technology Lab held 32,828 shares of C4 Therapeutics worth $153K as of Q2 2026.
C4 Therapeutics was a new Dynamic Technology Lab position in Q2 2026.
C4 Therapeutics made up 0.03% of Dynamic Technology Lab's portfolio in Q2 2026, its #577 holding.
Dynamic Technology Lab first reported a position in C4 Therapeutics in Q4 2021 and has held it in 7 quarters since.
Dynamic Technology Lab's C4 Therapeutics position peaked at $531K in Q1 2022.
148 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.